Published in Pediatrics on May 16, 2017
Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav (1995) 38.24
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry (1999) 13.56
Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry (2010) 11.11
Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA (2000) 9.58
Measuring diagnoses: ICD code accuracy. Health Serv Res (2005) 6.72
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics (2011) 5.46
Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol (1998) 5.35
Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES. Pediatrics (2009) 3.98
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (1999) 3.95
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol (2008) 3.63
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics (2004) 3.25
National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry (2003) 3.07
Child mental health and human capital accumulation: the case of ADHD. J Health Econ (2006) 2.74
Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. JAMA (2016) 2.61
Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr (2007) 2.36
Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2002) 2.32
Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol (2004) 2.30
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics (2004) 2.25
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 2.20
Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry (2001) 1.80
Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry (2001) 1.79
Knowledge and information about ADHD: evidence of cultural differences among African-American and white parents. Soc Sci Med (1998) 1.75
Barriers to detection, help-seeking, and service use for children with ADHD symptoms. J Behav Health Serv Res (2003) 1.75
Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev (2006) 1.57
Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program. J Am Acad Child Adolesc Psychiatry (2010) 1.55
Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2003) 1.44
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother (2007) 1.42
Misgivings of medicine?: African Americans' skepticism of psychiatric medication. J Health Soc Behav (2003) 1.36
Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med (2005) 1.26
Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years? Clin Psychol Rev (2008) 1.13
Who receives a diagnosis of attention-deficit/ hyperactivity disorder in the United States elementary school population? Pediatrics (2006) 1.08
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 1.05
Enhancing ADHD medication adherence: challenges and opportunities. Curr Psychiatry Rep (2013) 0.99
A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). Curr Psychiatry Rep (2008) 0.96
Ethnic differences in parental beliefs of attention-deficit/hyperactivity disorder and treatment. J Atten Disord (2009) 0.92
Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005. Psychiatr Serv (2012) 0.91
Changes and challenges: managing ADHD in a fast-paced world. J Manag Care Pharm (2007) 0.88
Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2012) 0.85
Geographic variation in receipt of psychotherapy in children receiving attention-deficit/hyperactivity disorder medications. JAMA Pediatr (2014) 0.81
The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities. J Child Adolesc Psychopharmacol (2013) 0.79
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin (2014) 0.76
Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry (2015) 3.89
Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States. JAMA Psychiatry (2014) 0.99
Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals. JAMA Psychiatry (2016) 0.78
Analysis of Mortality in Mental Disorders-Reply. JAMA Psychiatry (2015) 0.75
A Public Health Perspective on Mental and Medical Comorbidity. JAMA (2016) 0.75
Geographic Access to Specialty Mental Health Care Across High- and Low-Income US Communities. JAMA Psychiatry (2017) 0.75